Journal of Dermatological Science
Volume 30, Issue 2 , Pages 116-128 , November 2002

Th1, Th2 and Th3 cytokines in the pathogenesis of bullous pemphigoid

  • Barbara Giomi

      Affiliations

    • Department of Dermatological Science, University of Florence, Via degli Alfani 37, 50121 Florence, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39-055-275-8801; fax: +39-055-275-8757
    • ,
  • Marzia Caproni

      Affiliations

    • Department of Dermatological Science, University of Florence, Via degli Alfani 37, 50121 Florence, Italy
    • ,
  • Anna Calzolari

      Affiliations

    • Department of Oncology and Human Pathology, University of Florence, Florence, Italy
    • ,
  • Beatrice Bianchi

      Affiliations

    • Department of Dermatological Science, University of Florence, Via degli Alfani 37, 50121 Florence, Italy
    • ,
  • Paolo Fabbri

      Affiliations

    • Department of Dermatological Science, University of Florence, Via degli Alfani 37, 50121 Florence, Italy

Received 19 April 2002 ,Revised 17 June 2002 ,Accepted 19 June 2002.

References 

  1. Naito K, Morioka S, Ogawa H. The pathogenic mechanisms of blister formation in bullous pemphigoid. J. Invest. Dermatol. 1982;79:303–306
  2. Naito K, Morioka S, Ikeda S, Ogawa H. Experimental bullous pemphigoid in guinea pigs: the role of pemphigoid antibodies, complement and migrating cells. J. Invest. Dermatol. 1984;82:227–230
  3. Budinger L, Borradori L, Yee C. Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J. Clin. Invest. 1998;102:2082–2089
  4. Hertl M. Humoral and cellular autoimmunity in autoimmune bullous skin disorders. Int. Arch. Allergy Imunol. 2000;122:91–100
  5. Brocke S, Brautbar C, Steinman L. In vitro proliferative responses and antibody titres specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to MHC class II genes. J. Clin. Invest. 1900;82:1988
  6. Roitt IM. Autoantibodies in Hashimoto's disease (lymphadenoid goitre). Lancet. 1956;2:820–828
  7. Hertl M, Amagai H, Sundaram JR. Recognition of desmoglein 3 by autoreactive T-cells in pemphigus vulgaris patients and normals. J. Invest. Dermatol. 1998;110:62–66
  8. Caproni M, Giomi B, Cardinali C. Further support for a role of Th2-like cytokines in blister formation of pemphigus. Clin. Immunol. 2001;98:264–271
  9. Nestor MS, Cochran AJ, Ahmed AR. Mononuclear cell infiltrate in bullous diseases. J. Invest. Dermatol. 1987;88:172
  10. Dubertret L, Bertaux B, Fosse M, Touraine R. Cellular events leading to blister formation in bullous pemphigoid. Br. J. Dermatol. 1980;104:615–624
  11. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today. 1996;17:138
  12. Prud'homme GJ, Piccirillo CA. The inhibitory effect of transforming growth factor-β-1 (TGF-β1) in autoimmune diseases. J. Autoimmun. 2000;14:23–42
  13. Liblau RS, Singer SM, Mc Devitt HO. Th1 and Th2 CD4+ T-cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today. 1995;16:34–38
  14. Kaneko F, Minagawa T, Takiguchi Y. Role of cell-mediated immune reaction in blister formation of bullous pemphigoid. Dermatology. 1992;184:34–39
  15. Kaneko F, Minagawa T, Takiguchi Y. γ-Interferon in blister formation of bullous pemphigoid. J. Invest. Dermatol. 1989;92:456–460
  16. Giacalone B, D'Auria L, Ferraro C. Bullous pemphigoid blisters of the same duration have similar cytokine concentrations which decrease in older blisters. Br. J. Dermatol. 1998;139:158–159
  17. Rhodes LE, Hashim IA, Mc Laughlin PJ. Blister fluid cytokines in cutaneous inflammatory bullous disorders. Acta Derm. Venereol. 1999;79:288–290
  18. Ameglio F, D'Auria L, Bonifati C. Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: relationship with disease intensity. Br. J. Dermatol. 1998;13:611–614
  19. Wakugawa M, Nakamura K, Hino H. Elevated levels of eotaxin and IL-5 in blister fluid of bullous pemphigoid: correlation with tissue eosinophilia. Br. J. Dermatol. 2000;143:112–116
  20. Bhol KC, Rojas AI, Khan IU. Presence of IL-10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid. Cytokine. 2000;12:1076–1083
  21. Rico MJ, Benning C, Weingart ES. Characterization of skin cytokines in bullous pemphigoid and pemphigus vulgaris. Br. J. Dermatol. 1999;140:1079–1086
  22. Caproni M, Feliciani C, Fuligni A. Th2-like cytokine activity in dermatitis herpetiformis. Br. J. Dermatol. 1998;138:242–247
  23. Romagnani S. Type 1 and 2 lymphokines: polarized forms of the specific immune response. In:  Romagnani S editors. The Th1/Th2 paradigm in disease. Austin, TX, USA: RG Landes Company; 1996;p. 5–22
  24. Liu Z, Diaz JL, Troy AF. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J. Clin. Invest. 1993;92:2480–2488
  25. Wang JM, Rambaldi A, Biondi A. Recombinant human IL-5 is a selective eosinophil chemoattractant. Eur. J. Immunol. 1989;19:701–705
  26. Engineer L, Bhol K, Kumari S, Razzaque Ahmed A. Bullous pemphigoid. Interaction of interleukin-5, anti-basement membrane zone antibodies and eosinophils. A preliminary observation. Cytokine. 2001;13:32–38
  27. Dokter W, Esselink MT, Sierdsema SJ, Halie MR. Transcriptional and postranscriptional regulation of the interlekin 4 and interleukin 3 genes in human T-cells. Blood. 1993;81:35–40
  28. Clark EA, Shu GL, Lusher B. Activation of human B-cells. Comparison of the signal transduced by IL-4 to four different competence signals. J. Immunol. 1989;143:3873–3880
  29. Suzuki M, Harada S, Yaoita H. Purification of bullous pemphigoid IgG subclasses and their capability for complement fixation. Acta Derm. Venereol. 1992;72:245–249
  30. Kaminska R, Naukkarinen A, Glinski W. Mast cells in developing subepidermal bullous diseases: emphasis on tryptase, chymase and protease inhibitors. Acta Derm. Venereol. 1999;79:351–355
  31. Liu Z, Giudice GJ, Swartz SJ. The role of complement in experimental bullous pemphigoid. J. Clin. Invest. 1995;95:1539–1544
  32. Takiguchi Y, Itoh N, Suzuki M. The role of γ-interferon in blister formation of bullous pemphigoid. Jpn. J. Dermatol. 1991;25:101
  33. Roberts AB, Sporn MB. Physiological actions and clinical applications of transforming growth factor-β (TGF-β). Growth Factors. 1993;8:1–9
  34. Caproni M, Calzolari A, Salvatore E, Giomi B, Santucci M, Fabbri P. IL-4, IL-5, TGF-β1 and IFN-γ mRNAs detected by a new in situ amplification system in cicatricial pemphigoid. Exp Dermatol 2002;11.
  35. Derync R, Choy L. Transforming growth factor-β. In:  Thomson AW editors. The cytokine handbook. 3rd ed.. San Diego, USA: Academic Press; 1998;

PII: S0923-1811(02)00067-1

Journal of Dermatological Science
Volume 30, Issue 2 , Pages 116-128 , November 2002

Article Tools

* Image Usage & Resolution